Intralipid

Soybean oil, the active ingredient in Intralipid, is an intravenous lipid emulsion presented as a sterile lipid solution for intravenous use. It supplies calories and essential fatty acids to patients who cannot receive enteral feeding, helping to prevent essential fatty acid deficiency and to support nutritional needs in critically ill individuals.

GNH USA supplies Intralipid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide across multiple regions and healthcare institutions with reliable logistics.

Intralipid is used in parenteral nutrition to provide caloric and essential fatty acid support for patients unable to receive enteral feeding.

- Parenteral nutrition: supplies calories and essential fatty acids to sustain energy needs in patients without enteral intake. - Essential fatty acid deficiency prevention: delivers linoleic and alpha‑linolenic acids to avoid deficiency in long‑term lipid‑restricted feeding. - Critical illness support: offers supplemental caloric support for critically ill patients receiving total parenteral nutrition.

Intralipid may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Hypertriglyceridemia: elevated blood triglyceride concentrations during therapy. - Fever or chills: mild temperature rise or shaking during infusion. - Nausea: transient gastrointestinal discomfort reported by some patients. - Infusion site pain: discomfort or irritation at the catheter insertion point.

Serious or Rare Side Effects: - Fat overload syndrome: metabolic complications from excessive lipid load. - Anaphylactic reaction: severe allergic response that may require emergency treatment. - Pulmonary embolism: rare blockage of pulmonary vessels due to lipid particles. - Hepatic dysfunction: abnormal liver enzyme elevations indicating liver stress.

When using Intralipid, clinicians should observe specific precautions to minimize risks and ensure safe administration.

- Monitor triglyceride levels: check serum triglycerides regularly during therapy. - Assess for soy allergy: evaluate patient history for hypersensitivity to soy or egg phospholipids. - Use aseptic technique: maintain sterility of the infusion set and catheter. - Adjust dose in liver dysfunction: reduce infusion rate if hepatic impairment is present. - Avoid in severe hyperlipidaemia: contraindicated in patients with markedly elevated lipid levels. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intralipid can interact with other medications, affecting lipid metabolism or increasing the risk of adverse events.

Major Interactions (Avoid): - Propofol: concurrent lipid emulsions may cause severe hypertriglyceridemia. - High‑dose heparin: can further elevate triglyceride concentrations. - Gemfibrozil: may exacerbate lipid overload when combined with lipid emulsions.

Moderate Interactions (Monitor Closely): - Corticosteroids: can increase serum triglyceride levels, requiring monitoring. - Additional parenteral lipid formulations: cumulative lipid load may lead to overload. - Diuretics: may affect fluid balance during lipid infusion.